SCHEMBL28006708

SCHEMBL28006708

CN(C)C(CCN)S(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.33
LMNA P02545 1/20 0.33
SLC6A6 P31641 1/20 0.33
CYP2C19 P33261 1/20 0.33
BLM P54132 1/20 0.33
GABBR2 O75899 2/20 0.32
GABBR1 Q9UBS5 2/20 0.32
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573362 0.79 HDAC1 (0.37)
SCHEMBL918205 0.77 ALDH1A1 (0.31)
Hydrochloric Acid SCHEMBL27511908 0.75 ALOX15 (0.41) BLM
SCHEMBL527878 0.73
SCHEMBL29107349 0.73 TP53 (0.32)
SCHEMBL776175 0.72 TP53 (0.47) LMNA
SCHEMBL11710261 0.72 TP53 (0.47) LMNA
SCHEMBL27692090 0.71
Hydrochloric Acid SCHEMBL28093135 0.71
Water SCHEMBL29635525 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104593348-A FACTOR IX ANALOGUES WITH PROLONGED IN VIVO HALF-LIFE NOVO NORDISK HEALTHCARE AG 2015-05-06 CN disclosed